RE:RE:RE:RE:With any luck... This stock was at roughly 1.33 as recently as June and 1.25 in early July, just four or five weeks ago. BTI must have known then that they were going to need cash. Why didn't they finance back then? Did some sort of agreement for cash from a pharma unravel back then? Were there no other potential deals in sight?
Was the stock then walked down some 30 percent so that more shares and warrants would be available at a cheaper price to those allowed to buy them? It gives that appearance, at least to me, sad to say. That's a big, quick and possibly suspicious drop for a company that's supposed to be on the cutting edge in the bbb field.
I've apparently put too much faith in the science of this company while accusing my eyes of lying to me that the stock's tanking was signaling possiblr shenanigans.
I agree with oilpatch in questioning the need for so much cash if deals are imminent?
If they raise enough to last for a couple of years, my guess is that's what they're preparing for.
I'm half out and don't mind holding some dry powder. If the stock is going to 20 and more, I don't mind paying 5 or 6, as long as it's going in the right direction.